TY  -  
T1  - Cervical screening : ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC) 
SN  -  /  
UR  - http://hdl.handle.net/10138/333779 
T3  -  
A1  - Kyrgiou, Maria; Arbyn, Marc; Bergeron, Christine; Bosch, F. Xavier; Dillner, Joakim; Jit, Mark; Kim, Jane; Poljak, Mario; Nieminen, Pekka; Sasieni, Peter; Kesic, Vesna; Cuzick, Jack; Gultekin, Murat 
A2  -  
PB  -  
Y1  - 2020 
LA  - eng 
AB  - This paper summarises the position of ESGO and EFC on cervical screening based on existing guidelines and opinions of a team of lead experts. HPV test is replacing cytology as this offers greater protection against cervical cancer and allows longer screening intervals. Only a dozen of HPV tests are considered as clinically validated for screening. The lower specificity of HPV test dictates the use of triage tests that can select women for colposcopy. Reflex cytology is currently the only well va... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - HIGH-RISK HPV; INTRAEPITHELIAL NEOPLASIA; COST-EFFECTIVENESS; CANCER PRECURSORS; QUALITY-ASSURANCE; CYTOLOGY; WOMEN; GUIDELINES; TESTS; PERFORMANCE; 3122 Cancers 
N1  -   
PP  -  
ER  -